Franklin Biotechnology Discovery Fund

Portfolio Statistics

Assets

Total Fund AssetsAs of 05/31/2020 (updated monthly) $1,306.2 (M)
Net Assets - Class A As of 05/31/2020 (updated monthly) $1,061.5 (M)

Positions As of 05/31/2020

Equity VS. NASDAQ Biotechnology Index

Fund Benchmark
Market CapitalizationAs of 05/31/2020 (updated monthly) $32,962.62(M) $40,928.61(M)
P/B RatioAs of 05/31/2020 (updated monthly) 6.40 5.62
P/E Ratio (12-mo Forward)As of 05/31/2020 (updated monthly) 18.52 17.03
Price to Cash FlowAs of 05/31/2020 (updated monthly) 19.66 15.95

Portfolio Details

Asset AllocationAs of 06/30/2020

[name] [value]
Equity 95.65%
Cash & Cash Equivalents 4.35%

Geographic BreakdownAs of 06/30/2020

No chart available for this data.
[name] [value]
United States 82.65%
Cash & Cash Equivalents 4.35%
United Kingdom 4.07%
Netherlands 3.13%
Denmark 2.30%
Canada 2.08%
Switzerland 0.90%
Germany 0.54%

sector breakdownAs of 05/31/2020

[name] [value]
Biotechnology 78.50%
Pharmaceuticals 10.24%
Cash & Cash Equivalents 6.37%
Life Sciences Tools & Services 4.89%

TOP TEN HOLDINGSAs of 05/31/2020

Issuer Country Industry % of total
VERTEX PHARMACEUTICALS INC United States Pharmaceuticals, Biotechnology & Life Sciences 7.49%
REGENERON PHARMACEUTICALS INC United States Pharmaceuticals, Biotechnology & Life Sciences 6.96%
AMGEN INC United States Pharmaceuticals, Biotechnology & Life Sciences 5.60%
ILLUMINA INC United States Pharmaceuticals, Biotechnology & Life Sciences 4.89%
GILEAD SCIENCES INC United States Pharmaceuticals, Biotechnology & Life Sciences 4.79%
BIOGEN INC United States Pharmaceuticals, Biotechnology & Life Sciences 4.45%
GW PHARMACEUTICALS PLC United Kingdom Pharmaceuticals, Biotechnology & Life Sciences 3.96%
IOVANCE BIOTHERAPEUTICS INC United States Pharmaceuticals, Biotechnology & Life Sciences 3.49%
PTC THERAPEUTICS INC United States Pharmaceuticals, Biotechnology & Life Sciences 2.92%
ARGENX SE Netherlands Pharmaceuticals, Biotechnology & Life Sciences 2.83%

Market Capitalization BreakdownAs of 05/31/2020

[name] [value]
<2.0 Billion 16.31%
2.0-5.0 Billion 29.29%
5.0-10.0 Billion 9.53%
10.0-25.0 Billion 5.47%
25.0-50.0 Billion 2.55%
>50.0 Billion 36.51%
N/A 0.34%